OC

OKG Capital

Description

OKG Capital

Investor Profile

OKG Capital has made 7 investments, with 4 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (29%)
  • Series Unknown (29%)
  • Series A (29%)
  • Pre Seed (14%)

Country Focus

  • United States (43%)
  • United Kingdom (43%)
  • Germany (14%)

Industry Focus

  • Health Care
  • Medical
  • Software
  • Biotechnology
  • Health Diagnostics
  • Pharmaceutical
  • Therapeutics
  • Information Technology
  • Machine Learning
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OKG Capital frequently co-invest with?

VB
North America, Georgia, United States, Germany
Co-Investments: 1
Co-Investments: 1
Werth Ventures
North America, Connecticut, United States, Woodbridge
Co-Investments: 1
A
Europe, Bayern, Germany, Munich
Co-Investments: 1
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1
KHP Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Angel Investor Forum
North America, Connecticut, United States, Bristol
Co-Investments: 1
TR
North America, Connecticut, United States, Stamford
Co-Investments: 1
Macmillan Cancer Support
Europe, England, United Kingdom, London
Co-Investments: 2
Xcellerant Ventures
North America, Arizona, United States, Scottsdale
Co-Investments: 1

Which angels does OKG Capital often collaborate with?

NW
Europe, England, United Kingdom, London
Shared Deals: 1
OD
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
CB
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
AC
Europe, Berlin, Germany, Berlin
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by OKG Capital?

Aiomics

Berlin, Berlin, Germany

Unified Healthcare AI SaaS

Health CareMedicalSoftware
Pre SeedApr 19, 2025
OxCan

Oxford, Oxfordshire, United Kingdom

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

BiotechnologyHealth CareHealth Diagnostics
Series AJan 9, 2025
Amount Raised: $11,000,000
52 North Health

Cambridge, Cambridgeshire, United Kingdom

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Artificial Intelligence (AI)Health CareMedical
Series UnknownDec 3, 2024
Amount Raised: $6,000,000
iFast Diagnostics

Northampton, Northamptonshire, United Kingdom

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Health Care
SeedNov 4, 2024
Amount Raised: $6,477,154
DeepLook Medical

New Haven, Connecticut, United States

DeepLook Medical is a developer of a medical imaging software.

Health CareMedicalSoftware
Series ASep 18, 2024
DeepLook Medical

New Haven, Connecticut, United States

DeepLook Medical is a developer of a medical imaging software.

Health CareMedicalSoftware
SeedFeb 8, 2024
Amount Raised: $1,700,000
iQure Pharma

Wilmington, Delaware, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownOct 11, 2023
Amount Raised: $1,200,000
Halitus

Berlin, Berlin, Germany

Early disease detection with a portable, simple-to-use device. Turning air into data. Mixed Hardware + SaaS

Health DiagnosticsInformation TechnologyMachine LearningMedical Device
Pre SeedJul 5, 2023
Amount Raised: $1,085,516